I now have solid textbook evidence. Here is a thorough answer:
Can D25 (Dextrose 25%) Cause Weakness, Vertigo, and Blindness?
Yes - all three can occur, primarily through the metabolic and osmotic consequences of the concentrated glucose load. Here is how each happens:
Mechanisms
1. Hyperglycemia and Hyperosmolarity
D25 is a hypertonic solution (250 mg/mL of glucose). When infused, it rapidly raises blood glucose and serum osmolality. This creates several problems:
- Osmolality can exceed 330 mOsm/L in at-risk patients
- Cerebral dehydration occurs as water shifts out of brain cells into the hyperosmolar blood
- Hemoconcentration and prerenal azotemia follow
This is well-documented as Hyperosmolar Nonketotic Hyperglycemia - a syndrome where neurological signs are more prominent than in almost any other metabolic encephalopathy.
2. Weakness
Several pathways lead to muscle weakness:
| Cause | Mechanism |
|---|
| Hyperglycemic encephalopathy | CNS fatigue, stupor, hemiparesis |
| Hypokalemia | Dextrose drives K+ into cells (transcellular shift), causing muscle weakness and cramps |
| Refeeding syndrome | In malnourished/starved patients, rapid glucose load drops phosphate and magnesium, causing profound muscle weakness |
| Fluid/electrolyte imbalance | Hyponatremia from free water excess (dilutional) |
The textbook describes the classic picture of DKA/hyperosmolar states: "dehydration, fatigue, weakness, headache... stupor or coma" - Adams and Victor's Neurology.
3. Vertigo (Dizziness)
- Hyperosmolarity - affects vestibular and cerebellar function
- Hyponatremia - dilutional hyponatremia from dextrose metabolism (each gram of dextrose metabolized generates free water) can cause vertigo, nausea, and confusion
- Intracranial pressure changes - dextrose can worsen cerebral edema, raising ICP, which impairs brainstem/cerebellar function
- Rapid glucose correction - if given after prolonged hypoglycemia, the osmolality reversal gradient causes brain edema
4. Visual Disturbances / Blindness
This is the most serious complication:
- Homonymous visual field defects are specifically documented in hyperosmolar hyperglycemia - the textbook states: "Seizures and focal signs such as hemiparesis, hemisensory defect, choreoathetosis, or a homonymous visual field defect are more common than in any other metabolic encephalopathy" - Adams and Victor's Principles of Neurology, 12th Ed.
- Cerebral edema from rapid correction of hyperglycemia impairs occipital cortex perfusion
- Osmotic fluid shifts in the lens of the eye cause transient blurred vision/refractive changes - a well-known effect of rapid blood glucose changes
- Increased intracranial pressure can compress the optic nerve or disrupt visual pathways
Who Is Most At Risk?
- Neonates and infants (D25 is commonly used in NICUs - risk of IVH and cerebral injury)
- Diabetic patients - poor glucose tolerance amplifies hyperglycemia
- Malnourished/starved patients - risk of refeeding syndrome
- Elderly patients - reduced renal clearance, pre-existing vascular disease
- Patients with pre-existing cerebral injury - dextrose infusion significantly worsens ischemic brain injury (documented in studies)
Key Safety Points
- Never give D25 rapidly - slow controlled infusion is mandatory
- Monitor blood glucose frequently during infusion
- Check electrolytes (K+, Na+, Phosphate, Magnesium) before and during use
- Use a central line if possible to avoid vein damage and extravasation
- Taper slowly when stopping to prevent rebound hypoglycemia
- Avoid in patients with stroke/brain ischemia - hyperglycemia worsens cerebral infarction
So yes - D25 is a potent solution that must be used with caution. The weakness, vertigo, and visual loss you mention are real, documented neurological effects arising from hyperosmolarity, electrolyte shifts, cerebral edema, and focal neurological deficits caused by hyperglycemic encephalopathy.
Source: Adams and Victor's Principles of Neurology, 12th Edition - "Hyperglycemic Encephalopathy"